Breast Cancer

Right Breast Carcinoma

Female, 42 years

Patient Internal ID: 424408

ICD-10 code

C50.2 Malignant Neoplasm of Upper-inner Quadrant of Breast

Diagnosis (Incl. Metastases/Stage) and Year

April 2022
Right Breast Carcinoma pT1cN0M0 G3 ER(+), PR(-), HER2(-), LVI-1, R0, Ki67-60% Stage IA.

Previous Treatment

Surgery, Chemotherapy (Paclitaxel), Radiation Therapy, Hormone Therapy (Tamoxifen).

Prognosis and Survival Expectation

The prognosis for Localized Hormone Sensitive Breast Cancer is good, with a relative 5-year survival rate up to 95%.

Treatment Provided

Autologous DCV (7 doses) and CIK (8 doses) over a period of 9 months. Additionally, the patient received Immunostimulation of Interferon (IFN) β and Tumor Necrosis Factor (TNF) as well as Mistletoe Therapy.

Patient Survival/Condition and Year
Date of Review: 25/11/2023

The patient is alive, has a stable disease and no sign of disease progression. She continues hormonal treatment with Tamoxifen and is attending regular check-ups.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok